Abstract
Transcriptional profiling of a tumors entire genomic complement has become a key tool in the analysis of human cancers and identification of novel markers to predict disease state, outcome, and response to therapy. At present, this technology provides the most comprehensive approach for the analysis of somatic changes altering critical pathways during transformation of stable diploid cells into unstable tumor cells. Such analyses are impacting the development of novel anti-cancer drugs through the early detection of cancer, development of targeted therapies, identification of optimal dose and regimens for new drugs, and segmentation of patients to enrich response rates and reduce risk of adverse events.
Keywords: molecular profiling, pharmacogenomic, cancer, cytotoxic, tumorigenesis, translocations
Current Molecular Medicine
Title: Development of Oncology Drug Response Markers Using Transcription Profiling
Volume: 5 Issue: 1
Author(s): Nicholas C. Dracopoli
Affiliation:
Keywords: molecular profiling, pharmacogenomic, cancer, cytotoxic, tumorigenesis, translocations
Abstract: Transcriptional profiling of a tumors entire genomic complement has become a key tool in the analysis of human cancers and identification of novel markers to predict disease state, outcome, and response to therapy. At present, this technology provides the most comprehensive approach for the analysis of somatic changes altering critical pathways during transformation of stable diploid cells into unstable tumor cells. Such analyses are impacting the development of novel anti-cancer drugs through the early detection of cancer, development of targeted therapies, identification of optimal dose and regimens for new drugs, and segmentation of patients to enrich response rates and reduce risk of adverse events.
Export Options
About this article
Cite this article as:
Dracopoli C. Nicholas, Development of Oncology Drug Response Markers Using Transcription Profiling, Current Molecular Medicine 2005; 5 (1) . https://dx.doi.org/10.2174/1566524053152852
DOI https://dx.doi.org/10.2174/1566524053152852 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cellular and Molecular Mechanisms of Tumor-Induced T-Cell Tolerance
Current Cancer Drug Targets Polysaccharide Nanoparticles for Targeted Cancer Therapies
Current Drug Metabolism Cardiac Biomarkers in Acute Coronary Syndromes: A Review
Current Vascular Pharmacology S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular and Thermodynamic Studies on DNA Triplex Formed in the Promoter Region of HMGB1 Gene as a Selective Target for Anticancer Drugs
Anti-Cancer Agents in Medicinal Chemistry Future Targets for Immune Therapy in Colitis?
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Strategies for Targeting Prostate Cancer
Current Drug Delivery From 2D to 3D - a New Dimension for Modelling the Effect of Natural Products on Human Tissue
Current Pharmaceutical Design Amrubicin: A Synthetic Anthracyclin Analogue in the Treatment of Extensive Stage Small Cell Lung Cancer
Recent Patents on Anti-Cancer Drug Discovery Unveiling Cancer in IBD: Screening Colonoscopy or Chromoendoscopy
Current Drug Targets State of Research Tracks and Property Protection of Photodynamic Sensitizers and Delivery Methodologies
Recent Patents on Chemical Engineering Editorial Targeting the Metabolism of Cancer Cells- A Foreword
Current Pharmaceutical Design An Evidence-Based Research on Botanical Sources for Oral Mucositis Treatment in Traditional Persian Medicine
Current Drug Discovery Technologies Proteinases as Biomarkers in Breast Cancer Prognosis and Diagnosis
Mini-Reviews in Medicinal Chemistry The Role of Heme Oxygenase-1 in T Cell-Mediated Immunity: The All Encompassing Enzyme
Current Pharmaceutical Design The Redox Biology of Schistosome Parasites and Applications for Drug Development
Current Pharmaceutical Design Biomarker Metabolite Signatures Pave the Way for Electronic-nose Applications in Early Clinical Disease Diagnoses
Current Metabolomics Fighting Fire with Fire: A Patent for the Combined Application of Oncolytic Herpes Viruses and Antiangiogenic Agents in the Battle Against Human Cancers
Recent Patents on Anti-Cancer Drug Discovery DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
Current Pharmacogenomics SALL4: Engine of Cell Stemness
Current Gene Therapy